The Commercialisation Strategy Challenge
An early stage biotechnology company was seeking to develop a global/regional strategy for the commercialisation of their Phase I compound to maximise the value to the company over the potential life cycle of the product.
PharmaVentures conducted a detailed assessment of the market opportunities, technology risks and developments, launch and marketing costs via scenarios of “go-it-alone”, “outright sale”, “out-licensing for royalties” as well as “out-licensing with co-promotion”. The value generated was modelled and the scenarios were prioritised. Partnering and deal strategies were developed for the selected optimal strategy and incorporated into a business plan.